Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Rther_E' OR with Authors including 'Rther_E' OR with Abstract including 'Rther_E' OR with Keywords including 'Rther_E'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
Winter CA, Flataker L Further experiments on the performance of trained rats treated with ly... J. Pharmacol. Exper.... 1957
Hofmann A Rapport sur une auto-expérience avec le Psilocybe mexicana Heim Les champignons hall... 1958
Monnier M Action de la Psilocybine sur le cerveau du lapin Experientia 1959
Ernst AM Relation between the structure of certain methoxyphenylethylaminederiv... Psychopharmacologia 1965
Der Marderosian AH Nomenclatural History of the Morning Glory, Ipomoea violacea (L.) Taxon 1965
Pahnke WN, Kurland AA, Go... LSD-assisted psychotherapy with terminal cancer patients Psychedelic Drugs 1969
Pahnke WN, Kurland AA, Go... LSD-assisted psychotherapy with terminal cancer patients Curr Psychiatr Ther 1969
Shields PJ, Eccleston D Evidence for the Synthesis and Storage of 5-Hydroxytryptamine in Two S... J Neurochem 1973
Wallis DI, Woodward B The depolarizing action of 5-hydroxytryptamine on sympathetic ganglion... Brit..Pharmacol. 1973
Nomura J, Hisamatsu K, Ma... Stress and Cerebro-Hepatic Axis with Special Reference to Steroids Met... Psychoneuroendocrino... 1973
Stone TW Further evidence for a dopomine receptor stimulating action of an ergo... Brain Research 1974
Frontali M A Pharmacological Analysis of Processes Underlying Differential Respon... Behav. Biology 1976
Anton PG, Duncan ME, McGr... An Analysis of the Anatomical Basis for the Mechanical Response to Mot... J.Physiol. 1977
Kräuchi K, Feer H, Lichts... Specific in vivo Binding of d-LSD in Rat Brain Experientia 1978
Savona G, Paternostro MP,... Splendidin, a New trans-Clerodane from Salvia splendens Journal of the Chemi... 1979
Connell DJ, Middlemiss DN... Further evidence for an interaction of propranolol with the central 5-... Brit.J.Pharmacol. 1980
Editorial Arguments Heard for Psychedelics Probe Science 1980
Luscombe G, Jenner P, Mar... Myoclonus In Guinea Pigs Is Induced By Indole-containing But Not Piper... Life Sciences 1982
Schmidt MJ, Root MA, Hall... Dopamine Agonist Induced Hyperglycemia In Rats: Structure-activity;sRe... Europ.J.Pharmacol. 1983
Weaver KEC Letters to the Editor: LSD and Schizophrenia Arch. Gen. Psychiatr... 1984
Schechter MD Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... Pharmacol Biochem Be... 1988
Appel JB, Callahan PM Involvement of 5-HT receptor subtypes in the discriminative stimulus p... Eur J Pharmacol 1989
Bilsky EJ, Hui YZ, Hubbel... Methylenedioxymethamphetamine's capacity to establish place preference... Pharmacol Biochem Be... 1990
Ricaurte GA, Finnegan KT,... Aminergic metabolites in cerebrospinal fluid of humans previously expo... Ann N Y Acad Sci 1990
Pan HS, Wang RY MDMA: further evidence that its action in the medial prefrontal cortex... Brain Res 1991
Duffield PH, Jamieson D Development of tolerance to kava in mice Clin Exp Pharmacol P... 1991
Wichems CH, Hollingsworth... Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... Brain Res 1995
Hanes KR Serotonin, psilocybin, and body dysmorphic disorder: a case report. J Clin Psychopharmac... 1996
Buydens-Branchey L, Branc... Hormonal, psychological, and alcohol craving changes after m-chlorophe... Alcohol Clin Exp Res 1997
Bengel D, Murphy DL, Andr... Altered brain serotonin homeostasis and locomotor insensitivity to 3, ... Mol Pharmacol 1998
Bai F, Lau SS, Monks TJ Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine pr... Chem Res Toxicol 1999
McCann UD, Mertl M, Eligu... Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA... Psychopharmacology (... 1999
Baggott M, Mendelson J, J... More about parkinsonism after taking ecstasy N Engl J Med 1999
Burrows KB, Gudelsky G, Y... Rapid and transient inhibition of mitochondrial function following met... Eur J Pharmacol 2000
Al-Sahli W, Ahmad H, Kher... Effects of methylenedioxymethamphetamine on noradrenaline-evoked contr... Eur J Pharmacol 2001
Bhattachary S, Powell JH Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecsta... Psychol Med 2001
Croft RC, Macay AJ, Mills... The relative contributions of ecstasy and cannabis to cognitive impair... Psychopharmacology (... 2001
Verkes RJ, Gijsman HJ, Pi... Cognitive performance and serotonergic function in users of ecstasy Psychopharmacology (... 2001
Callahan BT, Cord BJ, Ric... Long-Term Impairment of Anterograde Axonal Transport Along Fiber Proje... Synapse 2001
Young R, Glennon RA The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinol... Pharmacol Biochem Be... 2002
Klitzman RL, Greenberg JD... MDMA ('ecstasy') use, and its association with high risk behaviors, me... Drug Alcohol Depend 2002
Glennon RA, Young R, Rang... Further characterization of the stimulus properties of 5,6,7,8- tetrah... Pharmacol Biochem Be... 2002
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Yuan J, Cord BJ, McCann U... Effect of glucoprivation on serotonin neurotoxicity induced by substit... J Pharmacol Exp Ther 2002
Cowan RL, Lyooa IK,Sunga ... Reduced cortical gray matter density in human MDMA (Ecstasy) users: a ... Drug and Alcohol Dep... 2003
Rodgers J, Buchanan T, Sc... Patterns of Drug Use and the Influence of Gender on Self-Reports of Me... J Psychopharmacology 2003
Daumann J, Hensen G, Thim... Self-reported psychopathological symptoms in recreational ecstasy (MDM... Psychopharmacology (... 2004
Farre M, De La Torre R, O... Repeated doses administration of MDMA in humans: pharmacological effec... Psychopharmacology (... 2004
Parks KA, Kennedy CL Club Drugs: Reasons for and Consequences of Use J Psychoactive Drugs 2004
de la Torre R, Farre M, M... Response to Sprague and Nichols: Contribution of metabolic activation ... Trends in Pharmacolo... 2005
LeBeau MA, Montgomery MA,... Further evidence of in vitro production of gamma-hydroxybutyrate (GHB)... Forensic Sci Int 2007
Marona-Lewicka D, Nichols... Further evidence that the delayed temporal dopaminergic effects of LSD... Pharmacol Biochem Be... 2007
Munro TA, Duncan KK, Xu W... Standard protecting groups create potent and selective kappa opioids: ... Bioorg Med Chem 2008
Starr MA, Page ME, Waterh... MDMA (3,4-methylenedioxymethamphetamine) - mediated distortion of soma... J Pharmacol Exp Ther 2008
Mueller MA, Yuan J, Neudo... Further Studies on the Role of Metabolites in MDMA-induced Serotonergi... Drug Metab Dispos 2009
Bisceglia KJ, Roberts AL,... Quantification of drugs of abuse in municipal wastewater via SPE and d... Anal Bioanal Chem 2010
Parrott AC Residual neurocognitive features of ecstasy use: a re-interpretation o... Addiction 2011
Halpern JH, Sherwood AR, ... Reply to Parrott (2011), Fisk et al (2011) and Rodgers et al (2011) Addiction 2011
Freyer CW, Peters M Palpable Purpura Complicated by Streptococcal Toxic Shock Syndrome Res... Pharmacotherapy 2012
Broman CL The Availability of Substances in Adolescence: Influences in Emerging ... Journal of Child & A... 2016
Saleemi S, Pennybaker SJ,... Who is 'Molly'? MDMA adulterants by product name and the impact of har... J Psychopharmacol 2017